Unifeye Vision Partners has partnered with Brooks Eye Associates, a prominent Texas ophthalmology practice, supported by a capital investment from Morgan Stanley Private Credit to enhance growth and patient care.

Information on the Target

Dallas, Texas-based Unifeye Vision Partners (UVP) has entered into a partnership with Brooks Eye Associates, an esteemed ophthalmology practice and surgery center located in Plano, Texas. Brooks Eye Associates, led by Dr. Dain B. Brooks, has been a staple in the Plano community since 2013, offering a wide range of eye care services such as cataract surgery, advanced refractive procedures, glaucoma treatments, and retinal care. The practice is also noted for its philanthropic involvement, with Dr. Brooks leading humanitarian missions in underserved regions including India, Mexico, and Ecuador, demonstrating a commitment to accessible vision care that complements UVP's core values.

The partnership will enable Brooks Eye Associates to leverage UVP's extensive resources and operational support while continuing to operate with clinical autonomy. The alignment between Brooks Eye Associates' dedication to patient-centered care and UVP's mission to enhance ophthalmic clinical and surgical care underscores the strategic fit of this collaboration.

Industry Overview in the Target's Specific Country

The ophthalmology market in the United States is experiencing significant growth, driven by an aging population and increasing prevalence of eye-related disorders. As advancements in technology enhance the effectiveness and accessibility of su

View Source

Similar Deals

New Mountain Capital Smarter Technologies

2025

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) United States of America
Advantage Capital Gravity Diagnostics

2025

Growth Equity & Expansion Capital Medical & Diagnostic Laboratories United States of America
Eir Partners Porter

2025

Growth Equity & Expansion Capital Home Healthcare Services United States of America
Ampersand Capital Partners Lexington Medical

2025

Growth Equity & Expansion Capital Medical Devices & Implants United States of America
Ampersand Capital Partners Gannet BioChem

2025

Growth Equity & Expansion Capital Biopharmaceuticals United States of America
WestView Capital Partners PharmaLink

2025

Growth Equity & Expansion Capital Pharmaceuticals (NEC) United States of America

Unifeye Vision Partners

invested in

Brooks Eye Associates

in 2025

in a Growth Equity & Expansion Capital deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert